# PHGR1

## Overview
PHGR1 is a gene that encodes the proline, histidine, and glycine-rich 1 protein, which is primarily expressed in the gastrointestinal tract, particularly in mature epithelial cells. This protein is characterized by its high content of proline, histidine, and glycine, contributing to its unique structural properties and stability. The PHGR1 protein is glycosylated and shares similarities with proline-rich salivary proteins and small proline-rich proteins (SPRRs), which are also known for their glycosylation and tandem repeats. Functionally, PHGR1 is involved in the differentiation and function of epithelial cells, playing a crucial role in nutrient absorption and cellular homeostasis. It is localized in both the cytoplasm and nucleus, with its nuclear presence increasing during cell differentiation, suggesting a role in cellular differentiation processes. Clinically, PHGR1 has been associated with various diseases, including colorectal cancer, prostate adenocarcinoma, diverticular disease, and breast cancer, where its expression levels may serve as a prognostic biomarker (Balraj2023PRADclass:; Schafmayer2019Genomewide; Lu2023Integrating; Conte2022In; Oltedal2018Expression).

## Structure
The PHGR1 protein is characterized by a high content of proline (29%), histidine (18%), and glycine (31%), resulting in a molecular weight of approximately 7.7 kDa (Oltedal2018Expression). The primary structure of PHGR1 includes five repeats of approximately 11 amino acids in the N-terminal region (Oltedal2018Expression). The protein is glycosylated, which is suggested by the presence of unexpected band sizes in Western blot analysis and confirmed by chemical deglycosylation, revealing a band at 10 kDa (Oltedal2018Expression). This glycosylation likely involves hydroxylation and O-glycosylation of prolines, as the protein has very few potential glycosylation sites (Oltedal2018Expression).

PHGR1 is expressed in the gastrointestinal tract, primarily in mature epithelial cells, and localizes to both the cytoplasm and nucleus (Oltedal2018Expression). The protein's structure poses challenges for homology-based structural analysis due to its high proline, histidine, and glycine content, but it shares characteristics with proline-rich salivary proteins and small proline-rich proteins (SPRRs), which are also glycosylated and have tandem repeats (Oltedal2018Expression). The protein's single lysine residue is a potential target for covalent modifications, although glycosylation is more likely (Oltedal2018Expression).

## Function
The PHGR1 gene encodes a protein that plays a significant role in the gastrointestinal epithelium, particularly in the differentiation and function of epithelial cells. This protein is highly expressed in mature epithelial cells, especially in the colonic mucosa, and is associated with secretory goblet cells and absorptive enterocytes, indicating its involvement in normal cellular functions such as nutrient absorption and cellular homeostasis (Oltedal2018Expression).

PHGR1 is localized in both the cytoplasm and nucleus, with nuclear levels increasing during cell differentiation, suggesting a role in cellular differentiation processes (Oltedal2018Expression). The protein is involved in transport and metabolic processes within the gastrointestinal epithelium, as evidenced by changes in gene expression related to these functions following PHGR1 knockdown in HT29 colon cancer cells (Oltedal2018Expression).

The protein's composition, rich in proline, histidine, and glycine, may influence its structural properties and stability, with glycosylation being a factor in its molecular weight (Oltedal2018Expression). PHGR1's activity in the gastrointestinal tract underscores its essential role in maintaining cellular homeostasis and supporting the normal function of epithelial cells (Oltedal2018Expression).

## Clinical Significance
PHGR1 has been implicated in several diseases through alterations in its expression levels. In colorectal cancer (CRC), high expression of PHGR1 is associated with a favorable prognosis, suggesting its potential role as a prognostic biomarker (Lu2023Integrating). The gene is also highlighted in prostate adenocarcinoma research, where it is identified as a top grade I-salient gene, indicating its involvement in less aggressive forms of the disease (Balraj2023PRADclass:).

In the context of diverticular disease, PHGR1 has been identified as a genetic locus with a stronger effect for diverticulitis, with an odds ratio of 1.32, suggesting that variations in this gene may significantly impact the risk of developing diverticulitis (Schafmayer2019Genomewide). However, the study did not find a strong disease-specific differential expression for PHGR1 across different layers in diverticulitis patients (Schafmayer2019Genomewide).

In breast cancer, PHGR1 is mentioned as one of the favorable prognostic genes, where higher expression correlates with better clinical outcomes, although the study primarily focuses on unfavorable prognostic genes (Conte2022In). These findings indicate that PHGR1 may play diverse roles in different cancer types, potentially influencing prognosis and disease progression.


## References


1. (Balraj2023PRADclass:) PRADclass: Multi-pronged Gleason grade-informed computational strategy identifies consensus biomarker features of prostate adenocarcinoma that predict aggressive cancer. This article has 0 citations.

[2. (Schafmayer2019Genomewide) Clemens Schafmayer, James William Harrison, Stephan Buch, Christina Lange, Matthias C Reichert, Philipp Hofer, François Cossais, Juozas Kupcinskas, Witigo von Schönfels, Bodo Schniewind, Wolfgang Kruis, Jürgen Tepel, Myrko Zobel, Jonas Rosendahl, Thorsten Jacobi, Andreas Walther-Berends, Michael Schroeder, Ilka Vogel, Petr Sergeev, Hans Boedeker, Holger Hinrichsen, Andreas Volk, Jens-Uwe Erk, Greta Burmeister, Alexander Hendricks, Sebastian Hinz, Sebastian Wolff, Martina Böttner, Andrew R Wood, Jessica Tyrrell, Robin N Beaumont, Melanie Langheinrich, Torsten Kucharzik, Stefanie Brezina, Ursula Huber-Schönauer, Leonora Pietsch, Laura Sophie Noack, Mario Brosch, Alexander Herrmann, Raghavan Veera Thangapandi, Hans Wolfgang Schimming, Sebastian Zeissig, Stefan Palm, Gerd Focke, Anna Andreasson, Peter T Schmidt, Juergen Weitz, Michael Krawczak, Henry Völzke, Gernot Leeb, Patrick Michl, Wolfgang Lieb, Robert Grützmann, Andre Franke, Frank Lammert, Thomas Becker, Limas Kupcinskas, Mauro D’Amato, Thilo Wedel, Christian Datz, Andrea Gsur, Michael N Weedon, and Jochen Hampe. Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms. Gut, 68(5):854–865, January 2019. URL: http://dx.doi.org/10.1136/gutjnl-2018-317619, doi:10.1136/gutjnl-2018-317619. This article has 86 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/gutjnl-2018-317619)

[3. (Lu2023Integrating) Di Lu, Xiaofang Li, Yuan Yuan, Yaqi Li, Jiannan Wang, Qian Zhang, Zhiyu Yang, Shanjun Gao, Xiulei Zhang, and Bingxi Zhou. Integrating tcga and single-cell sequencing data for colorectal cancer: a 10-gene prognostic risk assessment model. Discover Oncology, September 2023. URL: http://dx.doi.org/10.1007/s12672-023-00789-x, doi:10.1007/s12672-023-00789-x. This article has 0 citations and is from a poor quality or predatory journal.](https://doi.org/10.1007/s12672-023-00789-x)

[4. (Conte2022In) Federica Conte, Pasquale Sibilio, Anna Maria Grimaldi, Marco Salvatore, Paola Paci, and Mariarosaria Incoronato. In silico recognition of a prognostic signature in basal-like breast cancer patients. PLOS ONE, 17(2):e0264024, February 2022. URL: http://dx.doi.org/10.1371/journal.pone.0264024, doi:10.1371/journal.pone.0264024. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0264024)

[5. (Oltedal2018Expression) Satu Oltedal, Ivar Skaland, Jodi Maple-Grødem, Kjersti Tjensvoll, Emiel A. M. Janssen, Bjørnar Gilje, Rune Smaaland, Reino Heikkilä, and Oddmund Nordgård. Expression profiling and intracellular localization studies of the novel proline-, histidine-, and glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics. BMC Gastroenterology, February 2018. URL: http://dx.doi.org/10.1186/s12876-018-0752-8, doi:10.1186/s12876-018-0752-8. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12876-018-0752-8)